Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population

Pediatric Cardiology

Volumn 30, Issue 3, 2009, Pages 331-335

  Ban, Ju Yeon ^a   Yoon, Kyung Leem ^b   Kim, Su Kang ^a   Kang, Sungwook ^a   Chung, Joo Ho ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Coronary artery lesion; Kawasaki disease; Single nucleotide polymorphism; Tissue inhibitor of metalloproteinase 4

Indexed keywords

IMMUNOGLOBULIN; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

3' UNTRANSLATED REGION; ANALYZER; ARTICLE; CARDIOVASCULAR RISK; CHILD; COMORBIDITY; COMPUTER PROGRAM; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXON; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFANT; KOREA; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PROMOTER REGION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; DNA; FEMALE; GENOTYPE; HUMANS; INFANT; KOREA; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; PROGNOSIS; RISK FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 64249137466     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-008-9341-x     Document Type: Article

References (24)

1. J Abe 2008 Immunological aspects of Kawasaki disease Nippon Rinsho 66 267 271
2. AZ Baer LG Rubin CA Shapiro 2006 Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome Arch Pediatr Adolesc Med 160 686 690
3. AH Baker DR Edwards G Murphy 2002 Metalloproteinase inhibitors: Biological actions and therapeutic opportunities J Cell Sci 115 3719 3727
4. JC Barrett B Fry J Maller MJ Daly 2005 Haploview: analysis and visualization of linkage disequilibrium and haplotype maps Bioinformatics 21 263 265
5. PK Chua ME Melish Q Yu 2003 Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease Clin Diagn Lab Immunol 10 308 314
6. M Egeblad Z Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 161 174
7. PJ Gavin SE Crawford ST Shulman 2003 Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease Arterioscler Thromb Vasc Biol 23 576 581
8. K Ikeda K Ihara K Yamaguchi 2008 Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease Pediatr Res 63 182 185
9. MY Jung BS Kim YJ Kim 2008 Assessment of relationship between Fyn-related kinase gene polymorphisms and overweight/obesity in Korean population Korean J Physiol Pharmacol 12 83 87
10. I Koskivirta O Rahkonen M Mayranpaa 2006 Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology Histochem Cell Biol 126 335 342
11. HJ Lee GH Lee S Nah 2008 Association of TIMP-4 gene polymorphism with the risk of osteoarthritis in the Korean population Rheumatol Int 28 845 850
12. T Matsubara S Furukawa K Yabuta 1990 Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions Clin Immunol Immunopathol 56 29 36
13. T Matsuyama 1999 Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis Pediatr Int 41 239 245
14. N Moreno A Mendez-Echevarria J de Inocencio 2008 Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin Pediatr Cardiol 29 31 35
15. H Nagase JF Woessner Jr 1999 Matrix metalloproteinases J Biol Chem 274 21491 21494
16. JW Newburger M Takahashi MA Gerber 2004 Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic fever, Endocarditis, and Kawasaki disease, Council on Cardiovascular disease in the Young, American Heart Association Circulation 110 2747 2771
17. S Ogawa 2008 Biochemical and immunological laboratory findings in Kawasaki disease Nippon Rinsho 66 315 320
18. JA Park KS Shin YW Kim 2005 Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease J Korean Med Sci 20 607 611
19. Q Peng TF Zhou CH Chen 2005 Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease Zhonghua Er Ke Za Zhi 43 676 680
20. OP Rahkonen IM Koskivirta SM Oksjoki 2002 Characterization of the murine Timp4 gene, localization within intron 5 of the synapsin 2 gene, and tissue distribution of the mRNA Biochim Biophys Acta 1577 45 52
21. Research Committee on Kawasaki Disease (1984) Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Ministry of Health and Welfare, Tokyo, Japan
22. H Senzaki S Masutani J Kobayashi 2001 Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease Circulation 104 860 863
23. X Sole E Guino J Valls 2006 SNPStats: a Web tool for the analysis of association studies Bioinformatics 22 1928 1929
24. S Takeshita T Tokutomi H Kawase 2001 Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease Clin Exp Immunol 125 340 344